Emami Q4FY26: A summer-led drag, but portfolio transformation keeps moving

Emami closed Q4FY26 with a weak headline print, driven largely by a disrupted summer season and late-quarter geopolitical disruption in West Asia. Consolidated revenue from operations declined 3.9% year on year to INR925.1 crore, while EBITDA fell 14.9% to INR186.7 crore and profit after tax declined 11.7% to INR143.2 crore.

The company’s own framing is important here. It highlighted that the domestic business excluding the summer portfolio grew 11% in Q4FY26, suggesting underlying demand held up even as the summer portfolio fell sharply. International business, which had been strong through most of the quarter, ended Q4 down 5% due to shipping and supply-chain disruption linked to the West Asia conflict.

For FY26, consolidated revenue from operations was INR3,779.5 crore, down 0.8%. EBITDA was INR963.6 crore, down 6.0%, and PAT was INR775.3 crore, down 3.4%. While the year was challenging, Emami used the period to push its channel and portfolio shift, and to announce strategic investments intended to build the next leg of growth.

What drove the quarter: strong core portfolio, weak summer

In Q4FY26, Emami’s domestic business excluding the summer portfolio grew 11%. But the summer portfolio declined 22%, and management stated on the concall that talcum powders alone declined 40%. This seasonal impact, along with a high base and weather disruption, became the primary reason for the overall domestic decline.

The brand-range performance disclosed in the investor presentation shows a split view. Pain Management grew 11% in Q4FY26, the Kesh King range grew 14%, and the Healthcare range grew 7%. The company’s new-age brands The Man Company and Brillare grew 34%, and 7 Oils in One also grew 34%. Meanwhile, Navratna and Dermicool range declined 21% in Q4FY26, reflecting the summer disruption.

Channel-wise, the company continues to report a steady migration toward organised and new-age channels. Organised channels contributed about 32% to domestic business in FY26. On the concall, management also said wholesale channel dependency has reduced to 27% of total domestic sales, and called out quick commerce as a standout with 70% growth in Q4FY26.

Financial summary

Margins improved, but A&P intensity increased

Despite softer revenues, Emami expanded gross margins meaningfully in Q4FY26. Materials cost as a percentage of revenue declined to 31.6% from 34.1% in Q4FY25, supporting gross margin expansion to 68.4%.

However, EBITDA declined due to operating deleverage and higher investments behind brands. A&P spends rose 12.2% year on year and increased to 22.9% of revenues in Q4FY26. On the concall, management attributed the disproportionate increase largely to elevated advertising investments in Brillare, including a new product push.

For FY26, the trend is similar but less sharp. Materials cost as a share of revenues declined to 30.1% from 31.4%. Staff costs rose to 12.7% from 11.7%, and A&P costs rose to 19.6% from 18.2%.

International business: growth slowed by West Asia disruption

International business declined 5% in Q4FY26 and contributed 19% to overall sales. Management attributed the decline to the West Asia conflict, which impacted shipping routes through the Strait of Hormuz and increased freight costs, affecting operations across GCC, the Middle East, CIS and South Asian markets.

For FY26, international business grew 3% and contributed 18% to overall sales. Emami also disclosed the FY26 international contribution mix: SAARC and SEA contributed 40%, MENA 41%, and CIS 12%. The high weight of MENA explains why disruptions in West Asia can quickly affect quarterly performance.

Portfolio and channel transformation: the longer-term narrative

Emami has been explicit about changing its growth mix. The investor presentation highlighted that new-age and mainstream portfolio contribution to domestic business increased to 21% in FY26 from 7% in FY20, implying a five-year CAGR of 27% (as stated in the presentation). Organised and new-age channels rose to 32% from 12% over the same period. D2C brands contribution rose to 9% in FY26 from 0% in FY20.

The company also used Q1FY27 to strengthen this future-growth portfolio.

First, it increased its stake in Axiom Ayurveda, making it a subsidiary effective 1 April 2026, with the remaining stake acquisition expected by June 2026. Axiom’s flagship brand AloFrut is positioned as an aloe vera based fruit drink. On the concall, management said this is not a cola category, and also stated that Axiom is already profitable, with roughly INR40 to INR45 crore EBITDA.

Second, Emami announced it is acquiring a majority stake in IncNut, owner of digital-first brands Vedix and SkinKraft. Management described personalised beauty and personal care as a long-term growth opportunity in India and globally, aligned with consumer shift towards efficacy and customisation.

Balance sheet and dividends

Emami disclosed a net cash position of INR883 crore as of 31 March 2026. The company also declared interim dividends aggregating INR10 per share in FY26, with a total payout of INR436.5 crore. It stated the payout was 51% of adjusted PAT and 56% of reported PAT.

What to watch in FY27

Management’s early commentary suggests it expects improvement as seasonal conditions normalise. The company said early trends in Q1FY27 are encouraging, particularly across the summer portfolio. On the concall, management stated it is very confident that in the first half, Navratna and Dermicool will grow at double digits.

It also disclosed that price increases taken in the last one and a half to two months were around 3%. At the same time, management flagged that input cost pressure remains a watch item, referencing crude price behaviour.

Emami’s Q4FY26 performance was shaped by seasonality and geopolitics, but the disclosures on portfolio transformation, rising organised channel salience, and strategic investments in beverages and personalised beauty frame the company’s near-term volatility against a longer-term shift in where growth is expected to come from.